A national surveillance study was performed in order to identify the e
nterococci causing important infections, to determine their susceptibi
lities to first-choice agents for treatment, and to characterize the p
henotypes and genotypes of the glycopeptide-resistant strains. A total
of 472 isolates were collected between 15 January and 15 April 1993.
The ability of the API rapid ID 32 STREP gallery to identify enterococ
ci was evaluated, The majority of the Belgian enterococci were identif
ied as E. faecalis (89.4%), E. faecium and other enterococci were pres
ent in small percentages only (9.1 and 1.5%, respectively). The API ra
pid ID 32 STREP system identified 88.6% of the strains with an excelle
nt or very good identification score, For the majority of the strains
with uncertain identification scores, the results of a single test onl
y were aberrant, Only 2.3% of the strains remained unidentified, High-
level aminoglycoside resistance was widespread in E. faecalis (strepto
mycin, 50.8%; gentamicin, 8.7%), and the emergence of ciprofloxacin re
sistance was found to be associated with aminoglycoside resistance, E.
faecium is generally more resistant to a wide range of antibiotics, b
ut glycopeptide-resistant strains (1.5%) have not yet become widesprea
d.